• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗脱氧鸟苷白血病L1210细胞。特异性脱氧核糖核苷激酶活性丧失。

Deoxyguanosine-resistant leukemia L1210 cells. Loss of specific deoxyribonucleoside kinase activity.

作者信息

Cory A H, Shibley I A, Chalovich J M, Cory J G

机构信息

Department of Biochemistry, East Carolina University School of Medicine, Greenville, North Carolina 27858.

出版信息

J Biol Chem. 1993 Jan 5;268(1):405-9.

PMID:8380161
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1201387/
Abstract

A mouse leukemia L1210 cell line was selected for resistance to deoxyguanosine. The deoxyguanosine-resistant cells (dGuo-R) were 126-fold less sensitive to deoxyguanosine than the wild-type cells. The IC50 values for araC and araG were increased, but only 10-12-fold in the dGuo-R cells when compared with the wild-type cells. The dGuo-R cell line showed an increased level of resistance to 2-fluoro-2'-deoxyadenosine and 2-fluoroadenine arabinoside (11-14-fold), but essentially no increase in resistance to deoxyadenosine or adenine arabinoside. Deoxyribonucleoside kinase activity was decreased only slightly (19%) when deoxycytidine was utilized as substrate; when cytosine arabinoside or deoxyguanosine was used as the substrate, the kinase activity in the extracts from the dGuo-R cells was only 10% of the enzyme activity in the extracts from the wild-type cells. The determination of the kinetic parameters, Km and Vmax, indicated that there were marked decreases in the Vmax values for deoxyguanosine and cytosine arabinoside as substrates, but not for deoxycytidine as substrate; the Km values for deoxycytidine and cytosine arabinoside were increased in the extracts from the dGuo-R cells. By use of high-performance liquid chromatography, the kinase activities in the extracts from the wild-type and resistant cells could be resolved. There was the specific loss of kinase activity toward cytosine arabinoside and deoxyguanosine as substrates. These data indicate that the dGuo-R cells have decreased levels of a specific deoxyribonucleoside kinase activity.

摘要

选择一株对脱氧鸟苷具有抗性的小鼠白血病L1210细胞系。与野生型细胞相比,抗脱氧鸟苷细胞(dGuo-R)对脱氧鸟苷的敏感性低126倍。阿糖胞苷(araC)和阿糖鸟苷(araG)的IC50值升高,但与野生型细胞相比,dGuo-R细胞中的IC50值仅升高10 - 12倍。dGuo-R细胞系对2-氟-2'-脱氧腺苷和2-氟阿糖腺苷的抗性水平升高(11 - 14倍),但对脱氧腺苷或阿糖腺苷的抗性基本未增加。当以脱氧胞苷为底物时,脱氧核糖核苷激酶活性仅略有降低(19%);当以阿糖胞苷或脱氧鸟苷为底物时,dGuo-R细胞提取物中的激酶活性仅为野生型细胞提取物中酶活性的10%。动力学参数Km和Vmax的测定表明,以脱氧鸟苷和阿糖胞苷为底物时Vmax值显著降低,但以脱氧胞苷为底物时未降低;dGuo-R细胞提取物中脱氧胞苷和阿糖胞苷的Km值升高。通过高效液相色谱法,可以分辨野生型和抗性细胞提取物中的激酶活性。存在以阿糖胞苷和脱氧鸟苷为底物的激酶活性特异性丧失。这些数据表明,dGuo-R细胞中特定脱氧核糖核苷激酶活性水平降低。

相似文献

1
Deoxyguanosine-resistant leukemia L1210 cells. Loss of specific deoxyribonucleoside kinase activity.抗脱氧鸟苷白血病L1210细胞。特异性脱氧核糖核苷激酶活性丧失。
J Biol Chem. 1993 Jan 5;268(1):405-9.
2
Alterations in the properties of mouse leukemia L1210 cell lines selected by different methods for resistance to deoxyguanosine.
Adv Enzyme Regul. 1997;37:3-16. doi: 10.1016/s0065-2571(96)00006-4.
3
Use of nucleoside kinase-deficient mouse leukemia L1210 cell lines to determine metabolic routes of activation of antitumor nucleoside analogs.
Adv Enzyme Regul. 1994;34:1-12. doi: 10.1016/0065-2571(94)90005-1.
4
Effects of 2',2'-difluorodeoxycytidine (Gemcitabine) on wild type and variant mouse leukemia L1210 cells.2',2'-二氟脱氧胞苷(吉西他滨)对野生型和变异型小鼠白血病L1210细胞的作用。
Oncol Res. 1993;5(2):59-63.
5
Distinct sites for deoxyguanosine and deoxyadenosine phosphorylation on a monomeric kinase from Lactobacillus acidophilus.嗜酸乳杆菌单体激酶上脱氧鸟苷和脱氧腺苷磷酸化的不同位点。
Biochemistry. 1984 Dec 4;23(25):6235-40. doi: 10.1021/bi00320a053.
6
Identification of purine deoxyribonucleoside kinases from human leukemia cells: substrate activation by purine and pyrimidine deoxyribonucleosides.人白血病细胞中嘌呤脱氧核糖核苷激酶的鉴定:嘌呤和嘧啶脱氧核糖核苷对底物的激活作用
Biochemistry. 1987 Jan 27;26(2):590-7. doi: 10.1021/bi00376a034.
7
2'-Deoxy-2'-methylene derivatives of adenosine, guanosine, tubercidin, cytidine and uridine as inhibitors of L1210 cell growth in culture.腺苷、鸟苷、杀结核菌素、胞苷和尿苷的2'-脱氧-2'-亚甲基衍生物作为培养中L1210细胞生长的抑制剂。
Biochem Pharmacol. 1994 Jan 20;47(2):365-71. doi: 10.1016/0006-2952(94)90028-0.
8
Phosphorylation of anticancer nucleoside analogs by human mitochondrial deoxyguanosine kinase.人线粒体脱氧鸟苷激酶对抗癌核苷类似物的磷酸化作用。
Biochem Pharmacol. 1998 Oct 15;56(8):1035-40. doi: 10.1016/s0006-2952(98)00150-6.
9
Leukemia L1210 cell lines resistant to ribonucleotide reductase inhibitors.对核糖核苷酸还原酶抑制剂耐药的白血病L1210细胞系。
Cancer Res. 1988 Feb 15;48(4):839-43.
10
Role of deoxycytidine kinase in the inhibitory activity of 5-substituted 2'-deoxycytidines and cytosine arabinosides on tumor cell growth.脱氧胞苷激酶在5-取代2'-脱氧胞苷和阿糖胞苷对肿瘤细胞生长的抑制活性中的作用。
Mol Pharmacol. 1983 Jan;23(1):175-81.

引用本文的文献

1
New targets for pyrimidine antimetabolites for the treatment of solid tumours. 2: Deoxycytidine kinase.用于实体瘤治疗的嘧啶抗代谢物新靶点。2:脱氧胞苷激酶。
Pharm World Sci. 1994 Apr 15;16(2):104-12. doi: 10.1007/BF01880661.

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
The determination of enzyme inhibitor constants.酶抑制剂常数的测定
Biochem J. 1953 Aug;55(1):170-1. doi: 10.1042/bj0550170.
3
Inhibition of purine nucleoside phosphorylase by 8-aminoguanosine: selective toxicity for T lymphoblasts.8-氨基鸟苷对嘌呤核苷磷酸化酶的抑制作用:对T淋巴母细胞的选择性毒性。
Science. 1981 Dec 4;214(4525):1137-9. doi: 10.1126/science.6795718.
4
Effects of mutational loss of adenosine kinase and deoxycytidine kinase on deoxyATP accumulation and deoxyadenosine toxicity in cultured CEM human T-lymphoblastoid cells.腺苷激酶和脱氧胞苷激酶突变失活对培养的CEM人T淋巴母细胞中脱氧三磷酸腺苷积累及脱氧腺苷毒性的影响
J Biol Chem. 1982 Jun 10;257(11):6380-6.
5
Identification of the mechanism of activation of 9-beta-D-arabinofuranosyladenine in human lymphoid cells using mutants deficient in nucleoside kinases.利用核苷激酶缺陷型突变体鉴定人淋巴细胞中9-β-D-阿拉伯呋喃糖基腺嘌呤的激活机制。
Cancer Res. 1981 Nov;41(11 Pt 1):4478-83.
6
Differences in metabolism and cytotoxicity between 9-beta-D arabinofuranosyladenine and 9-beta-D-arabinofuranosyl-2-fluoroadenine in human leukemic lymphoblasts.人白血病淋巴母细胞中9-β-D-阿拉伯呋喃糖基腺嘌呤与9-β-D-阿拉伯呋喃糖基-2-氟腺嘌呤在代谢及细胞毒性方面的差异
Cancer Res. 1980 May;40(5):1405-10.
7
Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine.一种对1-β-D-阿拉伯呋喃糖基胞嘧啶具有高度抗性的脱氧胞苷激酶缺陷型人早幼粒细胞白血病细胞系的分离与鉴定
Cancer Res. 1984 Nov;44(11):5029-37.
8
Mammalian deoxynucleoside kinase. I. Deoxycytidine kinase: purification, properties, and kinetic studies with cytosine arabinoside.哺乳动物脱氧核苷激酶。I. 脱氧胞苷激酶:纯化、性质及与阿糖胞苷的动力学研究。
J Biol Chem. 1968 Aug 25;243(16):4298-304.
9
Metabolism and selective cytotoxicity of 9-beta-D-arabinofuranosylguanine in human lymphoblasts.
Cancer Res. 1985 Mar;45(3):1008-14.
10
Leukemia L1210 cell lines resistant to ribonucleotide reductase inhibitors.对核糖核苷酸还原酶抑制剂耐药的白血病L1210细胞系。
Cancer Res. 1988 Feb 15;48(4):839-43.